Adjunctive psychotropic medications during electroconvulsive therapy in the treatment of depression, mania, and schizophrenia

Journal of ECT

Volumn 26, Issue 3, 2010, Pages 196-201

  Haskett, Roger F ^a   Loo, Colleen ^b,c,d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c BLACK DOG INSTITUTE   (Australia)

^d ST GEORGE HOSPITAL   (Australia)

Author keywords

electroconvulsive therapy; major depression; mania; pharmacotherapy; schizophrenia

Indexed keywords

AMITRIPTYLINE; ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; DIAZEPAM; HALOPERIDOL; IMIPRAMINE; LORAZEPAM; OLANZAPINE; PHENELZINE; PLACEBO; PSYCHOTROPIC AGENT; RISPERIDONE; TRANYLCYPROMINE; VENLAFAXINE;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG MEGADOSE; ELECTROCONVULSIVE THERAPY; EVIDENCE BASED MEDICINE; HUMAN; MAINTENANCE THERAPY; MANIA; MOOD DISORDER; RELAPSE; REVIEW; SCHIZOPHRENIA; UNITED STATES;

BIPOLAR DISORDER; COMBINED MODALITY THERAPY; DEPRESSION; ELECTROCONVULSIVE THERAPY; HUMANS; PSYCHOTROPIC DRUGS; SCHIZOPHRENIA;

EID: 77956473419     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3181eee13f     Document Type: Review

References (53)

1. American Psychiatric Association. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training and Privileging. 2nd ed. Washington, DC: American Psychiatric Press; 2001.
2. Ellis P; Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Depression. Australian and New Zealand clinical practice guidelines for the treatment of depression. Aust N Z J Psychiatry. 2004;38:389Y407.
3. Scott AIF. Psychotropic drug treatment during and after ECT. In: Scott AIF, ed. The ECT handbook. 2nd ed. London, England: Royal College of Psychiatrists; 2005:109Y116.
4. Kalinowsky LB, Hoch PH. Shock Treatments and Other Somatic Procedures in Psychiatry. New York, NY: Grune & Stratton; 1946.
5. Hamilton M. The effect of treatment on the melancholias (depressions). Br J Psychiatry. 1982;140:223Y230.
6. Prudic J, Olfson M, Marcus SC, et al. Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry. 2004;55:301Y312.
7. Sackeim HA, Prudic J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med. 1993;328(12):839Y846.
8. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006; 63:1337Y1344.
9. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285:1299Y1307.
10. Sackeim HA. Continuation therapy following ECT: directions for future research. Psychopharmacol Bull. 1994;30:501Y521.
11. Dunlop E. Combination of antidepressants with electroshock therapy. Dis Nerv Syst. 1960;21:513Y514.
12. Ravn J. A comparison of past and present treatments of endogenous depression. Br J Psychiatry. 1966;112:501Y504.
13. Wilson IC, Vernon JT, Guin T, et al. A controlled study of treatments of depression. J Neuropsychiatry. 1963;4:331Y337.
14. Monaco JT, Delaplaine RP. Tranylcypromine with ECT. Am J Psychiatry. 1964;120:1003.
15. Nelson JP, Benjamin L. Efficacy and safety of combined ECT and tricyclic antidepressant drugs in the treatment of depressed geriatric patients. Convuls Ther. 1989;5:321Y329.
16. Kay D, Fahy T, Garside R. A seven-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. Br J Psychiatry. 1970;117:667Y671.
17. Seager CP, Bird RL. Imipramine with electrical treatment in depressionVa controlled trial. J Ment Sci. 1962;108:704Y707.
18. Imlah NW, Ryan E, Harrington JA. The influence of antidepressant drugs in the response to electroconvulsive therapy and subsequent relapse rates. Neuropsychopharmacology. 1965;4:438Y442.
19. Muller D. Nardil (phenelzine) as a potentiator of electroconvulsive therapy (E.C.T.). 2. A survey of outpatient E.C.T. J Ment Sci. 1961;107:994Y996.
20. Lauritzen L, Odgaard K, Clemmesen L, et al. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand. 1996;94:241Y251.
21. Mayur PM, Gangadhar BN, Subbakrishna DK, et al. Discontinuation of antidepressant drugs during electroconvulsive therapy: a controlled study. J Affect Disord. 2000;58:37Y41.
22. Baghai TC, Marcuse A, Brosch M, et al. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry. 2006;7:82Y90.
23. Prudic J, Haskett RF, Mulsant B, et al. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry. 1996;153:985Y992.
24. Gonzalez-Pinto A, Gutierrez M, Gonzalez N, et al. Efficacy and safety of venlafaxine-ECT combination in treatment-resistant depression. J Neuropsychiatry Clin Neurosci. 2002;14:206Y209.
25. Sackeim HA, Dillingham EM, Prudic J, et al. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes. Short-term efficacy and adverse effects. Arch Gen Psychiatry. 2009;66:729Y737.
26. Jha AK, Stein GS, Fenwick P. Negative interaction between lithium and electroconvulsive therapy; a case control study. Br J Psychiatry. 1996;168:241Y243.
27. Gupta S, Austin R, Devanand DP. Lithium and maintenance electroconvulsive therapy. J ECT. 1998;14:241Y244.
28. Stewart JT. Lithium and maintenance ECT. J ECT. 2000;16:300Y301.
29. Dolenc TJ, Rasmussen KG. The safety of electroconvulsive therapy and lithium in combination. A case series and review of the literature. J ECT. 2005;21:165Y170.
30. Alexander RC, Salomon M, Ionescu-Pioggia M, et al. Convulsive therapy in the treatment of mania: McLean Hospital 1973Y1986. Convuls Ther. 1988;4:115Y125.
31. Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a reviewof 50 years' experience. Am J Psychiatry. 1994;151:169Y176.
32. Sikdar S, Kulhara P, Avasthi A, et al. Combined chlorpromazine and electroconvulsive therapy in mania. Br J Psychiatry. 1994;164:806Y810.
33. Nascimento AL, Appolinario JC, Segenreich D, et al. Maintenance electroconvulsive therapy for recurrent refractory mania. Bipolar Disorders. 2006;8:301Y303.
34. Poyurovsky M, Weizman A. Safety and effectiveness of combined ECT and clozapine in treatment-resistant mania. Eur Psychiatry. 1996;11: 319Y321.
35. Chanpattana W. Combined ECT and clozapine in treatment-resistant mania. J ECT. 2000;16:204Y207.
36. Mohan TSP, Tharyan P, Alexander J, et al. Effects of stimulus intensity on the efficacy and safety of twice-weekly, bilateral electroconvulsive therapy (ECT) combined with antipsychotics in acute mania: a randomised controlled trial. Bipolar Disorders. 2009;11:126Y134.
37. Klapheke MM. Combining ECT and antipsychotic agents: benefits and risks. Convulsive Therapy. 1993;9:241Y255.
38. Braga RJ, Petrides G. The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia. J ECT. 2005;21:75Y83.
39. Kane JM, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45:789Y796.
40. Chanpattana W, Chakrabhand MLS. Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia: prediction of outcome. Psychiatry Res. 2001;105:107Y115.
41. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: APA; 1994.
42. Dombrovski AY, Mulsant BH, Haskett RF, et al. Predictors of remission after electroconvulsive therapy in unipolar depression. J Clin Psychiatry. 2005;66:1043Y1049.
43. Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev. 2009; Issue 4:CD000076. John Wiley and Sons.
44. National Institute for Clinical Excellence. Guidance on the Use of Electroconvulsive Therapy. Technology Appraisal 59. London: NICE; 2003.
45. Fink M. Clozapine and electroconvulsive therapy. Arch Gen Psychiatry. 1990;47:290Y291.
46. Meltzer HY. Clozapine and electroconvulsive therapy. Arch Gen Psychiatry. 1990;47:291.
47. Kupchik M, Spivak B, Mester R, et al. Combined electroconvulsive- clozapine therapy. Clin Neuropharmacol. 2000;23:14Y16.
48. Cardwell BA, Nakai B. Seizure activity in combined clozapine and ECT: a retrospective review. Convuls Therapy. 1995;11:110Y113.
49. Bloch Y, Mor I, Pollack M. Should the administration of ECT during clozapine therapy be contraindicated? Br J Psychiatry. 1996;169: 253Y254.
50. Tang W-K, Ungvari GS. Efficacy of electroconvulsive therapy in treatment-resistant schizophrenia: a prospective open trial. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:373Y379.
51. Hirose S, Ashby CR Jr, Mills MJ. Effectiveness of ECT combined with risperidone against aggression in schizophrenia. J ECT. 2001;17:22Y26.
52. Chanpattana W, Kramer BA. Acute and maintenance ECT with flupenthixol in refractory schizophrenia: sustained improvements in psychopathology, quality of life, and social outcomes. Schizophr Res. 2003;63:189Y193.
53. Hustig H, Onilov R. ECT rekindles pharmacological response in schizophrenia. Eur Psychiatry. 2009;24:521Y525.